Q1 2020 Holdings
Filed 2020-05-15 | 89 holdings | $929.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals(AUPH) | COM | 05156V102 | $617.0K | 42,500 | 66.3% |
| Bridgeline Digital Inc(BLIN) | COM | 10807Q700 | $73.0K | 110,000 | 7.8% |
| Sector HealthcarePut | ETF | 81369Y959 | $51.8K | 5,853 | 5.6% |
| Spdr S&P 500 ETF TRPut | ETF | 78462F953 | $38.7K | 1,500 | 4.2% |
| Ishares Russell 2000Put | ETF | 464287955 | $23.6K | 2,058 | 2.5% |
| Spdr Gold TrustPut | SHS | 78463V957 | $20.7K | 1,396 | 2.2% |
| Spdr Gold TrustCall | SHS | 78463V907 | $14.4K | 974 | 1.6% |
| Spdr Series TrustPut | ETF | 78464A950 | $13.7K | 1,769 | 1.5% |
| Sector HealthcareCall | ETF | 81369Y909 | $8.9K | 1,000 | 1.0% |
| Spdr S&P 500 ETF TRCall | ETF | 78462F903 | $8.6K | 334 | 0.9% |
| Ishares Nasdaq BiotechPut | ETF | 464287956 | $6.9K | 642 | 0.7% |
| Ishares Russell 2000Call | ETF | 464287905 | $4.4K | 385 | 0.5% |
| Sector Healthcare(XLV) | ETF | 81369Y209 | $3.0K | 34,410 | 0.3% |
| Gilead Sciences IncCall | COM | 375558903 | $2.8K | 2,166 | 0.3% |
| Spdr Gold Trust(GLD) | SHS | 78463V107 | $2.7K | 17,934 | 0.3% |
| Cel-Sci CorpPut | COM | 150837957 | $2.6K | 2,252 | 0.3% |
| Aveo Pharmaceuticals IncPut | COM | 053588957 | $2.4K | 10,248 | 0.3% |
| Novan Inc | COM | 66988N106 | $2.1K | 4,438,159 | 0.2% |
| Enlivex Therapeutics LTD(ENLV) | COM | M4130Y106 | $2.1K | 445,673 | 0.2% |
| Ishares Nasdaq BiotechCall | ETF | 464287906 | $2.0K | 189 | 0.2% |
| Outlook Therapeutics Inc(ONSGBP) | COM | 69012T206 | $1.9K | 3,232,342 | 0.2% |
| Brainstorm Cell IncPut | COM | 10501E951 | $1.9K | 4,041 | 0.2% |
| Aveo Pharmaceuticals IncCall | COM | 053588907 | $1.5K | 4,229 | 0.2% |
| Odonate Therapeutics Inc | COM | 676079106 | $1.4K | 48,988 | 0.1% |
| Fibrogen IncPut | COM | 31572Q958 | $1.3K | 361 | 0.1% |
| Odonate Therapeutics IncPut | COM | 676079956 | $1.2K | 445 | 0.1% |
| Trillium Therapeutics | COM | 89620X506 | $1.2K | 287,906 | 0.1% |
| Barclays IpathCall | ETF | 06745R903 | $1.2K | 250 | 0.1% |
| Pavmed Inc | *W | 70387R122 | $962 | 1,035,396 | 0.1% |
| Baudax BIO Inc | COM | 07160F107 | $927 | 373,977 | 0.1% |
| Tetraphase | COM | 88165N204 | $854 | 667,000 | 0.1% |
| Citius Pharmaceuticals | COM | 17322U207 | $813 | 1,354,275 | 0.1% |
| Pluristem TherapeuticsPut | COM | 72940R950 | $768 | 2,093 | 0.1% |
| Genocea Biosciences Inc(GNCAQ) | COM | 372427401 | $757 | 440,274 | 0.1% |
| Pluristem Therapeutics | COM | 72940R300 | $705 | 192,049 | 0.1% |
| BIO Path Hldgs Inc(BPTHEUR) | COM | 09057N300 | $694 | 154,290 | 0.1% |
| Ishares Russell 2000(IWM) | ETF | 464287655 | $675 | 5,900 | 0.1% |
| Cel-Sci Corp(CVM1EUR) | COM | 150837607 | $635 | 55,035 | 0.1% |
| Transenterix Inc | COM | 89366M300 | $619 | 1,760,262 | 0.1% |
| Amarin Corp PLC | ADR | 023111206 | $600 | 150,000 | 0.1% |
| Oramed Pharms IncPut | COM | 68403P953 | $550 | 1,809 | 0.1% |
| Sorrento Therapeutics(SRNE) | COM | 83587F202 | $529 | 287,386 | 0.1% |
| Phio Pharmaceuticals | COM | 71880W303 | $452 | 255,194 | 0.0% |
| Aurinia PharmaceuticalsCall | COM | 05156V902 | $448 | 309 | 0.0% |
| Aveo Pharmaceuticals Inc(0HJQ) | COM | 053588307 | $406 | 112,155 | 0.0% |
| Trillium TherapeuticsCall | COM | 89620X906 | $404 | 1,000 | 0.0% |
| Polarityte Inc | COM | 731094108 | $377 | 349,358 | 0.0% |
| Phasebio Pharmaceuticals | COM | 717224109 | $356 | 107,577 | 0.0% |
| Sorrento TherapeuticsPut | COM | 83587F952 | $289 | 1,569 | 0.0% |
| Cocrystal Pharma Inc | COM | 19188J300 | $278 | 392,206 | 0.0% |